Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M506939200 on September 13, 2005

J. Biol. Chem., Vol. 280, Issue 45, 37616-37622, November 11, 2005
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/45/37616    most recent
M506939200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waas, W. F.
Right arrow Articles by Schimmel, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waas, W. F.
Right arrow Articles by Schimmel, P.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Discovery of a Gene Family Critical to Wyosine Base Formation in a Subset of Phenylalanine-specific Transfer RNAs*

William F. Waas{ddagger}, Valérie de Crécy-Lagard§1, and Paul Schimmel{ddagger}2

From the {ddagger}Department of Molecular Biology and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La, Jolla, California 92037 and the §Department of Microbiology and Cell Science, University of Florida, Gainesville, Florida 32611

Received for publication, June 27, 2005 , and in revised form, August 29, 2005.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 CONCLUSION
 REFERENCES
 
A large number of post-transcriptional base modifications in transfer RNAs have been described (Sprinzl, M., Horn, C., Brown, M., Ioudovitch, A., and Steinberg, S. (1998) Nucleic Acids Res. 26, 148-153). These modifications enhance and expand tRNA function to increase cell viability. The intermediates and genes essential for base modifications in many instances remain unclear. An example is wyebutosine (yW), a fluorescent tricyclic modification of an invariant guanosine situated on the 3'-side of the tRNAPhe anticodon. Although biosynthesis of yW involves several reaction steps, only a single pathway-specific enzyme has been identified (Kalhor, H. R., Penjwini, M., and Clarke, S. (2005) Biochem. Biophys. Res. Commun. 334, 433-440). We used comparative genomics analysis to identify a cluster of orthologous groups (COG0731) of wyosine family biosynthetic proteins. Gene knock-out and complementation studies in Saccharomyces cerevisiae established a role for YPL207w, a COG0731 ortholog that encodes an 810-amino acid polypeptide. Further analysis showed the accumulation of N1-methylguanosine (m1G37) in tRNA from cells bearing a YPL207w deletion. A similar lack of wyosine base and build-up of m1G37 is seen in certain mammalian tumor cell lines. We proposed that the 810-amino acid COG0731 polypeptide participates in converting tRNAPhe-m1G37 to tRNAPhe-yW.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 CONCLUSION
 REFERENCES
 
In all organisms, the functions of tRNAs in translation are enhanced by a series of post-transcriptional modifications (4). Over 80 modifications are known, and their presence vastly expands the structural and chemical diversity of native tRNA (2). (In a putative RNA world, base modifications may have provided a way to diversify the chemical and structural properties of RNAs.) The modification-dependent structural stability and function correlate with increased cellular fitness and viability (5, 9). The importance of these modifications is underscored by a large investment of resources for their biosynthesis, with estimates suggesting nearly 1% of some bacterial genomes being dedicated to tRNA modification genes (4).

Wyebutosine (yW)3 of yeast phenylalanine-specific tRNA (tRNAPhe) was one of the earliest tRNA modifications to be discovered (10-14). Wyebutosine is a fluorescent, tricyclic base and a member of the wyosine family of hypermodified guanosines. All wyosine bases (Ybs) are characterized by a 1H-imidazo[1,2-{alpha}]purine core structure and a strict occurrence in archaeal and eukaryal tRNAPhe (Figs. 1 and 2). Wyosine bases, isolated from different organisms, show variations in ring methylation and side chain structure (15-20). Generally, archaeal Yb structures are less differentiated then their eukaryotic counterparts.

The hydrophobic nature of yW37 promotes stacking with adjacent bases (A36 and A38) and restricts the conformational flexibility of the anticodon (21-25). Removal of yW produced local changes in anticodon conformation, as well as long range perturbations in tRNAPhe tertiary structure (26). These structural changes were accompanied by subtle differences in codon specificity4 and a modest increase in retroviral ribosomal frameshifting (determined in cell-free extract) (27-29). Most interesting, the tRNAPhe from mouse neuroblastoma cell lacked Yb but was more efficient than the fully modified tRNAPhe in a cell-free translation system (30-32). Although it is unclear if hypomodified tRNAs contribute to tumor-specific properties, these tRNAs support the high levels of translation required by rapidly dividing cells. Thus, despite a good understanding of its role in maintaining anticodon structure, the function of yW in translation is unclear.

Although the biosynthesis of wyebutosine has been partially characterized, the genes involved are largely unknown. Several structural components of yW were identified by metabolic labeling experiments. The purine substructure was shown as being derived from the coded guanosine (33, 34). NMR studies of 13C-enriched tRNAPhe implicated the methyl group of methionine as a source for carbon-10 (refer to Fig. 1 for numbering), and for the side chain ester and N3-methyl moieties (35). Conflicting evidence obscures understanding the origin of the 3-amino-3-carboxypropyl side chain (36, 37). The in vivo kinetics of Yb biosynthesis of Xenopus laevis were investigated (34). By using the site-specifically labeled [32P]tRNAPhe transcript in X. laevis oocytes, Droogmans and Grosjean (34) detected N1-methylguanosine (m1G) and an unknown compound "X" as intermediates, and they suggested that the pathway may involve numerous metabolites.

The recent expansion of publicly available bioinformatics tools and data bases has stimulated gene identification and functional assignment. Novel approaches, which combine public genome information with genetic context, have met with success in linking unknown genes to definitive functions (38-42). In this study, our methodology produced a single "hit" that allowed us to identify a pathway-specific polypeptide-encoding gene that acts downstream from the initial modification event (m1G37). Deletion of the gene in Saccharomyces cerevisiae produces tRNAPhe in a modification state similar to that in certain mammalian cell types, including some tumor cell lines.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 CONCLUSION
 REFERENCES
 
Strains and Chemicals—Wild-type and deletion strains ({Delta}YPL207w) of S. cerevisiae were purchased from Open Biosystems (www.openbiosystems.com). Both strains were of the MAT{alpha} leu2{Delta}0 met15{Delta}0 ura3{Delta}0 genotype. The YPL207w ORF was replaced with a KanR cassette in the null strain. All chemicals were obtained in high purity from Sigma unless otherwise noted.

Plasmids—YPL207w was cloned from S. cerevisiae genomic DNA by PCR (30 cycles, 1 min at 94 °C, 1 min at 55 °C, and 6 min at 68 °C) using the following oligonucleotides: 5'-ggggacaagtttgtacaaaaaagcaggctatggatccaataatggatggttttcgtgtagctgg-3' and 5'-ctccctcctattcctgcttaagctttacccagctttcttgtacaaagtggtcccc-3'. The gene was incorporated into pYES-DEST52 (Invitrogen) between the att1 and att2 sites by site-specific recombination using manufacturer-suggested protocols. The vector carried the URA3 marker for auxotrophic selection and a PGAL1 for protein expression. The expression vector for yeast phenyalanyl-tRNA synthetase was a gift from Dr. David Tirrell, California Institute of Technology.

Phylogenetic Queries—The occurrence of wyosine in tRNAPhe from several organisms was determined from a data base of annotated tRNA sequences. The genomes of organisms containing (Methanococcus jannaschi, Homo sapiens, Saccharomyces cerevisiae, Schizosaccharomyces pombe, and Arabidopsis thaliana) or lacking (Drosophila melanogaster, Escherichia coli, and Bacillus subtilis) the wyosine modification were analyzed using the comparative genomics platform, Protein Link Explorer (PLEX) (43). A BLAST E-value of 10-10 was set as a threshold for gene identification.

Bulk tRNA Purification—Bulk tRNA was isolated from yeast cells grown in synthetic complete medium (± uracil) containing 2% galactose. Cultures (2 liters) were grown at 30 °C to an absorbance at 600 nm (A600) of 0.6-1.2. Cells were pelleted by centrifugation and rinsed with 10 mM sodium acetate (pH 4.5). The pellet was resuspended in 100 ml of 0.3 M sodium acetate (pH 4.5), 10 mM EDTA before the addition of 100 ml of water-saturated phenol. After 30 min of vigorous shaking, the phases were separated by centrifugation (5,000 rpm, 20 min). Nucleic acids were precipitated from the aqueous phase with 0.4 volumes of isopropyl alcohol. Precipitate was collected as a pellet (30 min at 10,000 rpm) and dissolved in 10 ml of NB1 buffer (100 mM Tris acetate (pH 6.3), 0.5 mM EDTA, 0.75 M KCl). Reconstituted nucleic acids were loaded onto a Nucleobond AX-500 column equilibrated in NB2 buffer (100 mM Tris acetate (pH 6.3), 15% ethanol, and 400 mM KCl). The column was then washed with 30 ml of the same buffer before elution with 12 ml of NB3 buffer (100 mM Tris acetate (pH 6.3), 15% ethanol, and 650 mM KCl). The eluted RNA was precipitated with isopropyl alcohol, washed with 70% ethanol, and lyophilized.

Expression and Purification of Yeast Phenylalanyl-tRNA Synthetase— Yeast His6-PheRS was overexpressed in E. coli as described previously (44). All subsequent purification steps were performed at 4 °C. Cells pelleted from 2 liters of culture were resuspended in 30 ml of lysis buffer (20 mM Tris (pH 7.5), 5 mM MgCl2, 0.1% {beta}-mercaptoethanol, and protease inhibitor mixture (Roche Diagnostics)) and lysed by sonication. The lysate was cleared by centrifugation (18,000 rpm for 30 min). Yeast His6-PheRS was purified by batch affinity chromatography using nickelnitrilotriacetic-agarose beads according to the manufacturer's protocol (Qiagen, Valencia, CA) (45). Purified protein was dialyzed into HPLC buffer A (20 mM Tris (pH 7.5) and 0.1% {beta}-mercaptoethanol) and loaded on to a Mono Q HR 5/5 column. Yeast His6-PheRS was eluted from the column using linear gradient of NaCl (0-1 M, HPLC buffer A) at a flow rate of 1 ml/min. Fractions containing yeast tRNAPhe amino acylation activity were pooled and dialyzed against storage buffer (20 mM HEPES-HCl (pH 7.5), 100 mM KCl, 2 mM dithiothreitol, and 10% glycerol). Purified yeast His6-PheRS was finally concentrated to >3 mg/ml and snap-frozen in liquid N2 for storage at -80 °C.

Aminoacylation of tRNAPhe with Yeast PheRS—Aminoacylation of tRNAPhe was performed in buffer containing 25 mM HEPES-HCl (pH 7.5), 10 mM MgCl2, 100 mM KCl, 2 mM dithiothreitol, 2 mM ATP, 160 µM [3H]phenylalanine (800-5,000 cpm/pmol). The total concentration of tRNAPhe per reaction was limited to 10 µM. Reactions were initiated with enzyme (100 nM yeast His6-PheRS) and incubated for 45 min at 27 °C. [3H]Phenylalanyl-tRNAPhe was quantified as described previously (46).

Identical reaction conditions were used for large scale phenylalanyl-tRNAPhe production. However, reactions were quenched with 3 M sodium acetate (0.3 M final (pH 4.5)). Yeast PheRS was then removed by phenol/chloroform extraction before the tRNAPhe was precipitated from the aqueous layer with ethanol. Phe-tRNAPhe was resuspended in RP1 buffer (10 mM sodium phosphate (pH 4.5), 1 M sodium formate, and 8 mM MgCl2) prior to reverse-phase chromatography.

Thin Layer Chromatography Analysis of Acid-hydrolyzed Wyebutosine—Pure, lyophilized tRNA (100 µg) was reconstituted in 500 µl of 50 mM sodium phosphate (pH 3.5) and incubated at 37 °C for 18 h to hydrolyze wyebutosine from tRNAPhe. The base was then extracted with ethyl acetate (500 µl). Ethyl acetate was removed under reduced pressure to produce a white residue. The residue was redissolved in a small volume of ethyl acetate and spotted on a Silica Gel 60 F254 TLC plate (EM Science, Gibbstown, NJ). The sample was then chromatographed using the upper layer of a 1-propyl alcohol/ethyl acetate/water (1:4:2) mixture as the mobile phase (19). Fluorescent material was visualized by excitation at 300 nm.

Fractionation of tRNA by Reverse-phase HPLC—Purified bulk tRNA (1-2 mg) was loaded onto a Vydac C4 semi-preparative HPLC column (catalog number 214TP1010) equilibrated in buffer RP1 (10 mM sodium phosphate (pH 4.5), 1 M sodium formate, and 8 mM MgCl2). A linear gradient to 100% buffer RP2 (10 mM sodium phosphate (pH 4.5) and 15% methanol) was established over 70 min at a flow rate of 4 ml/min. Fractions were collected every 0.5 min and analyzed for phenylalanine acceptance as described above.

MALDI—Mass measurements were made using an Applied Biosystems DE system. A salt-tolerant matrix, 2,4,6-trihydroxyacetophenone containing diammonium citrate was used to analyze purified tRNA. Ions were monitored in positive mode. Masses were calculated from an average of 300 scans.

Enzymatic Digestion of tRNAPhe—HPLC-purified tRNA (100 µg) was resuspended in 0.1 ml of 10 mM ammonium acetate (pH 5.3). The tRNA was incubated with nuclease P1 (8 units, Sigma) at 45 °C for 2 h. Fresh ammonium bicarbonate was added to a final concentration of 0.1 M before the addition of snake venom phosphodiesterase (0.008 units, Sigma). The mixture was incubated for an additional 2 h at 37°C. Nucleosides were dephosphorylated by incubation with alkaline phosphatase (4 units, New England Biolabs, Beverly, MA) for 1 h at 37°C. Digested tRNA was lyophilized prior to LC-MS analysis.

Liquid Chromatography-Mass Spectrometry of tRNAPhe Hydrolysates— LC electrospray ionization mass spectrometry was performed on an Agilent MSD 1100. The system was equipped with a Supelcosil LC-18-S HPLC column (25 cm x 4.6 mm, 5 µM). Prior to chromatography the column was equilibrated in LC-MS buffer A (250 ammonium acetate (pH 6.0)). Nucleosides were eluted using a segmented, linear gradient of LC-MS buffer B (40% acetonitrile). The gradient profile was as follows: 0 min, 0% B; 6 min, 0% B; 8.8 min, 0.2% B; 11.6 min, 0.8% B; 14.4 min, 1.8% B; 17.2 min, 3.2% B; 20 min, 5% B; 50 min, 25% B; 60 min, 50% B; 68 min, 75% B; 74 min, 75% B; 90 min, 100% B; and 96 min, 100% B. A flow rate of 0.5 ml/min was maintained during each run/ and the eluate was analyzed in positive ion mode.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 CONCLUSION
 REFERENCES
 
Identification of COG0731 as a Probable Wyebutosine Synthesis Gene— For the purpose of guiding comparative genomics queries, a compilation of tRNA sequence and modification data were analyzed for the occurrence of wyosine family compounds in organisms with sequenced genomes (1, 3, 47-52). Yb is absent from eubacteria and present in many archaeal and eukaryotic phenylalanine-specific tRNAs (Figs. 1 and 2). Significantly, D. melanogaster tRNAPhe harbors N1-methylguanosine at position 37 instead of Yb (53). By using this information and a Protein Link Explorer (PLEX) algorithm (43), a phylogenetic occurrence query identified genes present in M. jannaschi, H. sapiens, S. cerevisiae, S. pombe, and A. thaliana but not in D. melanogaster, E. coli, or B. subtilis. A single gene family COG0731 fit the desired criteria and belongs to PACE (proteins in Archaea conserved in eukaryotes) Group 22 (54).

Although the biological role of COG0731 is generally unknown, many characterized PACE-encoding genes are implicated in the organization and processing of genetic material, including rRNA/tRNA maturation and modification (54, 55). Consequently, these genes show correlated expression with genes sharing related biological functions. Analysis of gene expression in yeast (www.yeastgenome.org) revealed that during the cell cycle and in response to DNA-damaging agents, COG0731 family members co-express with genes for ribosome biogenesis, RNA processing, and RNA metabolism (p > 10-5).



View larger version (18K):
[in this window]
[in a new window]
  		FIGURE 1.
Chemical structures of wyosine-family bases isolated from M. jannaschii (a), H. sapiens (b), S. cerevisiae (c), and 4-demethylwyosine (ImG-14) (d). COOCH3, methyl ester; NHCOOCH3, methylcarbamate; OOH, peroxy.

 



View larger version (9K):
[in this window]
[in a new window]
  		FIGURE 2.
Phylogenetic occurrence of wyosine bases in sequenced genomes. Refer to Fig. 1 for chemical structures.

 
Yeast Strains Lacking the COG0731 Ortholog Do Not Produce Acilabile Wyebutosine—YPL207w is the S. cerevisiae COG0731 ortholog. To assess the significance of COG0731 to Yb biosynthesis, wild-type and the {Delta}YPL207w deletion strain of S. cerevisiae were assayed for wyebutosine production. Bulk tRNA from each strain was incubated at pH 3.5 and at 37 °C for several hours (under these conditions the wyebutosine base (yW) is hydrolyzed from tRNAPhe by cleavage of the N-C bond (56)). The liberated base was then isolated by extraction with ethyl acetate, and the extracts were concentrated and spotted on silica gel plates. After thin layer chromatography (Fig. 3), a single fluorescent spot (RF = 0.47)5 was detected in extracts prepared from the wild-type strain, and mass spectrometric analysis of this fluorescent material gave a mass of 377.1 Da corresponding to that of yW (57). Extracts from the {Delta}YPL207w deletion strain lacked the fluorescent material. Thus, the {Delta}YPL207w deletion blocks Yb biosynthesis.

RP-HPLC Analysis of tRNAPhe from Wild-type and Gene Deletion Strains of S. cerevisiae—To confirm that the absence of Yb from acid-treated tRNA from the {Delta}YPL207w deletion strain correlated with an alteration of the tRNA itself, the chromatographic properties of tRNAPhe from wild-type (tRNAPhewt and null (tRNAPhe{Delta}ypl207w) strains were compared. Bulk tRNA from each strain was fractionated using RP-HPLC (Vydac C-4 column), and the presence of tRNAPhe was analyzed by testing each fraction for [3H]phenylalanine acceptance (Fig. 4, A-C) (58). Although viable tRNAPhe from each strain eluted as a single peak,6 they had markedly different retention times (tRNAPhewt = 49.5 min, tRNAPhe{Delta}ypl207w = 18.0 min). The early elution time of tRNAPhe{Delta}ypl207w fits with a more hydrophilic, hypomodified state for that tRNA. Similar shifts have been reported for yeast tRNAPhe after removal of yW by acid treatment, as well as for mammalian tRNAPhe isolated from rat hepatomas that were hypomodified (m1G) at position 37 (59). Because all tRNAPhe{Delta}ypl207w occurs in a single rapidly eluting peak, the {Delta}YPL207w deletion appears to block completely the synthesis of yW in S. cerevisiae. These results confirm that the absence of yW from acid-treated tRNA from {Delta}YPL207w deletion strain is due to a deficiency in tRNAPhe modification.

Complementation in the Null Strain by Expression of YPL207w in Trans—Aware that polar effects may result from disruption of YPL207w with KanR, we turned to genetic complementation to provide evidence that the phenotype of the {Delta}YPL207w strain is because of a single gene disruption. For these experiments, the 810-amino acid ORF of YPL207w was cloned into the pYES-DEST52 expression vector. The {Delta}YPL207w deletion strain was transformed with the recombinant vector and then grown under conditions that ensured continuous gene expression. Total tRNA was isolated, and chromatography of the tRNA revealed peaks (a and b) at ~49.5 and 18.0 min (Fig. 4C). These retention times are the same as those of tRNAPhewt and tRNAPhe{Delta}ypl207w, respectively. Acid treatment of peak b fractions produced a fluorescent, ethyl acetate-soluble compound with an RF (0.47) and mass (377.1) identical to that of wyebutosine. No yW was detected in peak a fractions. The observation of two peaks was presumed to result from partial complementation. (complete complementation was achieved when cells were harvested at higher optical densities (A600 > 2.0 (Fig. 4C, inset)). Thus, expression of YPL207w in the {Delta}YPL207w deletion strain restores wyebutosine biosynthesis and rules out downstream polar effects caused by KanR insertion.



View larger version (34K):
[in this window]
[in a new window]
  		FIGURE 3.
Thin layer chromatography analysis of acid hydrolyzed wyebutosine. Bulk tRNA (100 µg) was purified from wild-type (WT) and YPL207w-deleted ({Delta}YPL207w) strains of S. cerevisiae. yW was hydrolyzed from tRNA with acid and extracted with ethyl acetate. Concentrated samples were spotted and developed using the upper layer of an ethyl acetate/propyl alcohol/H2O (4:2:1) mixture. Compounds were excited with UV irradiation (300 nm).

 
Purification and Mass Determination of tRNAPhe and Identification of a Wyebutosine Precursor by LC/MS of tRNAPhe Hydrolysates—Because disruption of YPL207w produced a hypomodified and chromatographically homogenous tRNAPhe species, we inferred that an intermediate or yW precursor had accumulated at position 37. To identify intermediates, transfer RNAPhewt was obtained at high purity (amino acid acceptance = 1969 ± 53 pmol/A260 (60)) using the fractionation procedure described above (TABLE ONE). By contrast, tRNAPhe{Delta}ypl207w co-eluted with other tRNA species (154 pmol/A260) and had to be esterified with phenylalanine (using yeast PheRS) to increase the retention time (48.5 min) and resolve it (1836 ± 108 pmol/A260) from other tRNA species.


View this table:
[in this window]
[in a new window]
  		TABLE ONE
Physical properties of tRNAPhe isolated from S. cerevisiae

 
MALDI mass spectroscopy was used for tRNA molecular weight determination (TABLE ONE). The observed mass for tRNAPhewt (24,953.8 ± 4.7 Da) was nearly identical to the value reported by Taniguchi and Hayashi (61) (24,953.4 ± 3.5 Da). The observed mass for tRNAPhe{Delta}ypl207w (24 745.1 ± 4.8 Da) differed from that of tRNAPhewt by 208.7 ± 4.8 Da.



View larger version (19K):
[in this window]
[in a new window]
  		FIGURE 4.
Reverse-phase liquid chromatography of bulk tRNA. Bulk tRNA (1 mg) was loaded onto a Vydac C4 semipreparative HPLC column equilibrated in 10 mM sodium phosphate (pH 4.5), 1 M sodium formate, and 8 mM MgCl2. A linear gradient to 10 mM sodium phosphate (pH 4.5) and 15% methanol was established over 70 min at 4 ml/min. Fractions were collected every 0.5 min and analyzed for [3H]phenylalanine acceptance as described under "Materials and Methods." Absorbance at 260 nm and [3H]phenylalanine incorporation are indicated as solid and dotted lines, respectively. Profiles of tRNA isolated from wild-type (A), YPL207w-deleted (B), and complementation strains (C) are presented. Inset, tRNA from complementation strains harvested at A600 >2.0.

 
Tandem liquid chromatography/mass spectroscopy (LC/MS) was used to analyze tRNA nucleoside composition. For this procedure, tRNAs were extensively digested and dephosphorylated, and nucleosides were resolved by RP-HPLC, under a set of standardized conditions (17, 62, 63). Mass (100-600 m/z) and UV absorption (254, 280, 310 nm) data were collected from the eluents and, along with relative retention times,7 were used to assign nucleoside identities according to the work of Edmonds et al. (62). Absorbance and mass profiles for the tRNAPhewt hydrolysate (Fig. 5A) were consistent with the known composition of S. cerevisiae tRNAPhe, with masses for 14 of the 15 ribonucleosides expected for the tRNAPhe being observed (5-methyluridine was not detected, whereas inosine (peak 3b) occurred at ~36 min and was attributed to adenosine deaminase activity in commercial preparations of nuclease P1.8 Peak 9 corresponds to yW and does not appear in the spectrum of tRNAPhe{Delta}ypl207w (Fig. 5B). The loss of yW coincided with only one other change, a substantial increase in absorbance of the peak for 2'-O-methylguanosine (Gm, peak 5*). Extensive mass scanning over the limits of the peak 5* revealed fragment ions not observed for the Gm peak of tRNAPhewt (5th peak, Fig. 6A). The most abundant new ion is observed at 166.0 m/z, the expected mass of a base-methylated guanosine (Fig. 6B) (62). Methylation of G37 fits with the molecular weight differences of tRNAPhewt and tRNAPhe{Delta}ypl207w ({Delta}Mm(expected) = 211 Da, {Delta}Mm(observed) = 208.7 Da; where Mm indicates molecular mass). Relative retention time and co-elution with Gm suggests these ions are produced by N1-methylguanosine (m1G). Only two other base-methylated guanosines are known to occur in RNA-7-methylguanosine (m7G) and N2-methylguanosine (m2G). These ribonucleosides are accounted for in each spectrum as peaks 3a and 6, respectively, and thus can be eliminated as candidate structures. The homogeneous elution of tRNAPhe{Delta}ypl207w during RP-HPLC chromatography and the nearly quantitative doubling (1.96-fold)9 of peak 5 absorbance indicate stoichiometric methylation of G37 in cells lacking YPL207w.


   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
CONCLUSION
 REFERENCES
 
A comparative genomics analysis was used to link YPL207w to yW biosynthesis. The analysis was initially limited to organisms with completely sequenced genomes and fully characterized tRNAPhe. The phylogenetic distribution of Yb and conservation among these organisms (which include Archaea, fungi, plants, and mammals) suggests that it is among the earliest tRNA modifications to occur after branching of Archaea and eukaryotes from eubacteria. Further review of the tRNA data base indicated that in Bombyx mori the tRNAPhe contains m1G37, and analysis of several other complete genome sequences revealed that Caenorhabditis elegans and Encephalitozoon cuniculi lack COG0731 orthologs. Like D. melanogaster, these organisms are not equipped to synthesize Yb. Phenylalanine-specific tRNAs of eubacteria also lack Yb, but instead have another highly modified purine at position 37 (2-methylthio-N6-isopentenyladenosine). The 2-methylthio-N6-isopentenyladenosine modification affects anticodon structure, codon recognition, and translational efficiency in a way that is similar to Yb (6, 64). Therefore, tRNAPhe from eubacteria is distinct from that of eukaryotic organisms that harbor m1G37.



View larger version (16K):
[in this window]
[in a new window]
  		FIGURE 5.
HPLC of tRNA hydrolysates. Purified tRNAPhe from wild-type (A) and YPL207w-deleted strain of S. cerevisiae (B) were enzymatically digested to nucleosides. A multistep acetonitrile gradient was used to resolve nucleosides over a Supelcosil column. Peaks between 30 and 75 min are displayed. Mass and relative retention times were used to assign nucleoside identities. 1, 5-methylcytidin; 2, 2'-O-methylcytidine; 3, 7-methylguanosine/inosine; 4, guanosine; 5, 2'-O-methylguanosine; 5*, 2'-O-methylguanosone/N1-methylguanosine; 6, N2-methylguanosine; 7, adenosine; 8, N2,N2-dimethylguanosine; and 9, wyebutosine.

 
Deletion of YPL207w in yeast blocked wyebutosine production and caused methylated guanosine (G37) to accumulate in tRNAPhe. We suggest that methylation occurs at N1 of G37. This modification (m1G37) was reported in several cell types that produce hypomodified tRNAPhe. For example, in mouse neuroblastoma, 85% of tRNAPhe contained m1G37 (65, 66). A significant portion of rabbit reticulocyte tRNAPhe also had m1G37 instead of peroxywyebutosine (28). Furthermore, eukaryotic organisms that do not synthesize Yb (e.g. D. melanogaster and B. mori) produce tRNAPhe bearing m1G37. These data demonstrate the natural occurrence of m1G37 during tRNAPhe biosynthesis and fit well with our assignment.

Droogmans and Grosjean (34) provided direct evidence that tRNAPhe (m1G37) is an integral part of yW biosynthesis. They showed that the transcript synthesized with m1G37 is a competent pathway intermediate and established m1G37 as the obligatory first step in Yb biosynthesis in X. laevis oocytes. Subsequently, the enzyme responsible for G37 methylation was discovered to be an archaeal/eukaryl specific m1G37 methyltransferase (8, 67). Deletion of the S. cerevisiae, methyltransferase-encoding gene (TRM5), prevents formation of both m1G37 and yW (67). Representatives from the m1G37-methyltransferase gene family are found in all organisms that synthesize Yb. Based on the accumulation of m1G in our study, we hypothesize that YPL207w supports a biosynthetic step immediately after synthesis of m1G37.



View larger version (16K):
[in this window]
[in a new window]
  		FIGURE 6.
ESI mass spectroscopy of tRNA nucleosides. Scans performed over peak 5 (A) and peak 5* (B). Theoretical molecular weights are as follows: Na·M+ = 320 m/z; MH+ = 298 m/z; (m1G) = 166 m/z; (Gm) = 152 m/z; Me-SH+ = 149 m/z; SH+ = 135 m/z.

 
Because COG0731 genes occur in organisms that produce "minimalist" wyosine bases such as 4-demethylwyosine (Fig. 1d), the COG0731 gene product may not be involved in formation of eukaryotic Yb side chains. This suggestion is supported by the work of Kalhor et al. (7) which demonstrated that tRNA from S. cerevisiae lacking the TRM12 gene contained 4-demethylwyosine (structure d, Fig. 1) rather than yW (7).


   CONCLUSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 CONCLUSION
REFERENCES
 
In this study, YPL207w was identified as essential for wyebutosine biosynthesis in yeast. A {Delta}YPL207w deletion strain produced tRNAPhe that was fully modified except at position 37 (m1G37). N1-G37-methylated tRNAPhe is a putative intermediate of the yW biosynthetic pathway. Currently, it is not known whether the protein translated from the YPL207w ORF directly modifies tRNAPhe-m1G or contributes to tRNAPhe-yW biosynthesis by some indirect means. Thus, the biochemical activity of the YPL207w gene product requires further investigation.


   FOOTNOTES
 
* This work was supported by Grants GM15539 and 23562 from the National Institutes of Health, a fellowship from the National Foundation for Cancer Research (to P. S.), and a Ruth L. Kirschstein National Research Service Award from the National Institutes of Health (to W. F. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

1 To whom correspondence may be addressed: Dept. of Microbiology and Cell Science, University of Florida, P. O. Box 110700, Gainesville, FL 32611-0700. Tel.: 352-392-9416; Fax: 352-392-5922; E-mail: vcrecy{at}ufl.edu. 2 To whom correspondence may be addressed: Dept. of Molecular Biology and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037. Tel.: 858-784-8970; Fax: 858-784-8990; E-mail: schimmel{at}scripps.edu.

3 The abbreviations used are: yW, wyebutosine; HPLC, high pressure liquid chromatography; LC-MS, liquid chromatography-mass spectrometry; RP, reverse-phase; ORF, open reading frame; Ybs, wyosine bases; m1G, N1-methylguanosine; PheRS, phenylalanyl-tRNA synthetase; Gm. 2'-O-methylguanosine. Back

4 It should be noted that these studies are performed with tRNA lacking any base at position 37. Back

5 A similar RF (0.48) value was reported for yeast yW by Nakanishi et al. (19). Back

6 The high specific activity of [3H]phenylalanine (5,000 cpm/pmol) used during labeling would have enabled detection of rare tRNAPhe species present at less than 0.5% the quantity of the major tRNAPhe peak. Back

7 Retention times are discussed in relation to those of A, U, G, and C. Back

8 Adenosine deaminase activity was verified by enzymatic assay. Back

9 Determined by A254 peak integration. The m2G peak (peak 6) was used as an internal standard. Back


   ACKNOWLEDGMENTS
 
We thank Dr. Henri Grosjean for sharing unpublished results and for helpful advice and discussions.



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 CONCLUSION
 REFERENCES
 

  1. Sprinzl, M., Horn, C., Brown, M., Ioudovitch, A., and Steinberg, S. (1998) Nucleic Acids Res. 26, 148-153[Abstract/Free Full Text]
  2. Grosjean, H., Sprinzl, M., and Steinberg, S. (1995) Biochimie (Paris) 77, 139-141
  3. Steinberg, S., Misch, A., and Sprinzl, M. (1993) Nucleic Acids Res. 21, 3011-3015[Free Full Text]
  4. Björk, G. R., Ericson, J. U., Gustafsson, C. E., Hagervall, T. G., Jonsson, Y. H., and Wikstrom, P. M. (1987) Annu. Rev. Biochem. 56, 263-287[CrossRef][Medline] [Order article via Infotrieve]
  5. Persson, B. C. (1993) Mol. Microbiol. 8, 1011-1016[Medline] [Order article via Infotrieve]
  6. Bouadloun, F., Srichaiyo, T., Isaksson, L. A., and Björk, G. R. (1986) J. Bacteriol. 166, 1022-1027[Abstract/Free Full Text]
  7. Kalhor, H. R., Penjwini, M., and Clarke, S. (2005) Biochem. Biophys. Res. Commun. 334, 433-440[Medline] [Order article via Infotrieve]
  8. Christian, T., Evilia, C., Williams, S., and Hou, Y. M. (2004) J. Mol. Biol. 339, 707-719[CrossRef][Medline] [Order article via Infotrieve]
  9. Björk, G. R., Durand, J. M., Hagervall, T. G., Leipuviene, R., Lundgren, H. K., Nilsson, K., Chen, P., Qian, Q., and Urbonavicius, J. (1999) FEBS Lett. 452, 47-51[CrossRef][Medline] [Order article via Infotrieve]
  10. RajBhandary, U. L., and Chang, S. H. (1968) J. Biol. Chem. 243, 598-608[Abstract/Free Full Text]
  11. Chang, S. H., and RajBhandary, U. L. (1968) J. Biol. Chem. 243, 592-597[Abstract/Free Full Text]
  12. RajBhandary, U. L., Stuart, A., and Chang, S. H. (1968) J. Biol. Chem. 243, 584-591[Abstract/Free Full Text]
  13. RajBhandary, U. L., Faulkner, R. D., and Stuart, A. (1968) J. Biol. Chem. 243, 575-583[Abstract/Free Full Text]
  14. RajBhandary, U. L., Stuart, A., Hoskinson, R. M., and Khorana, H. G. (1968) J. Biol. Chem. 243, 565-574[Abstract/Free Full Text]
  15. McCloskey, J. A., Liu, X. H., Crain, P. F., Bruenger, E., Guymon, R., Hashizume, T., and Stetter, K. O. (2000) Nucleic Acids Symp. Ser. 267-268
  16. Zhou, S., Sitaramaiah, D., Noon, K. R., Guymon, R., Hashizume, T., and McCloskey, J. A. (2004) Bioorg. Chem. 32, 82-91[Medline] [Order article via Infotrieve]
  17. McCloskey, J. A., Graham, D. E., Zhou, S., Crain, P. F., Ibba, M., Konisky, J., Soll, D., and Olsen, G. J. (2001) Nucleic Acids Res. 29, 4699-4706[Abstract/Free Full Text]
  18. Noon, K. R., Guymon, R., Crain, P. F., McCloskey, J. A., Thomm, M., Lim, J., and Cavicchioli, R. (2003) J. Bacteriol. 185, 5483-5490[Abstract/Free Full Text]
  19. Nakanishi, K., Blobstein, S., Funamizu, M., Furutachi, N., Van Lear, G., Grunberger, D., Lanks, K. W., and Weinstein, I. B. (1971) Nat. New Biol. 234, 107-109[Medline] [Order article via Infotrieve]
  20. Blobstein, S. H., Grunberger, D., Weinstein, I. B., and Nakanishi, K. (1973) Biochemistry 12, 188-193[Medline] [Order article via Infotrieve]
  21. Stuart, J. W., Koshlap, K. M., Guenther, R., and Agris, P. F. (2003) J. Mol. Biol. 334, 901-918[CrossRef][Medline] [Order article via Infotrieve]
  22. Kan, L. S., Ts'o, P. O., von der Haar, F., Sprinzl, M., and Cramer, F. (1975) Biochemistry 14, 3278-3291[Medline] [Order article via Infotrieve]
  23. Maelicke, A., von der Haar, F., and Cramer, F. (1973) Biopolymers 12, 27-43[Medline] [Order article via Infotrieve]
  24. Sussman, J. L., Holbrook, S. R., Warrant, R. W., Church, G. M., and Kim, S. H. (1978) J. Mol. Biol. 123, 607-630[CrossRef][Medline] [Order article via Infotrieve]
  25. Holbrook, S. R., Sussman, J. L., Warrant, R. W., and Kim, S. H. (1978) J. Mol. Biol. 123, 631-660[CrossRef][Medline] [Order article via Infotrieve]
  26. Krzyzosiak, W. J., and Ciesiolka, J. (1983) Nucleic Acids Res. 11, 6913-6921[Abstract/Free Full Text]
  27. Ghosh, K., and Ghosh, H. P. (1972) J. Biol. Chem. 247, 3369-3375[Abstract/Free Full Text]
  28. Carlson, B. A., Kwon, S. Y., Chamorro, M., Oroszlan, S., Hatfield, D. L., and Lee, B. J. (1999) Virology 255, 2-8[CrossRef][Medline] [Order article via Infotrieve]
  29. Carlson, B. A., Mushinski, J. F., Henderson, D. W., Kwon, S. Y., Crain, P. F., Lee, B. J., and Hatfield, D. L. (2001) Virology 279, 130-135[CrossRef][Medline] [Order article via Infotrieve]
  30. Mazabraud, A. (1979) FEBS Lett. 100, 235-240[Medline] [Order article via Infotrieve]
  31. Smith, D. W., McNamara, A. L., Mushinski, J. F., and Hatfield, D. L. (1985) J. Biol. Chem. 260, 147-151[Abstract/Free Full Text]
  32. Shugart, L. (1972) Exp. Gerontol. 7, 251-262[Medline] [Order article via Infotrieve]
  33. Li, H. J., Nakanishi, K., Grunberger, D., and Weinstein, I. B. (1973) Biochem. Biophys. Res. Commun. 55, 818-823[Medline] [Order article via Infotrieve]
  34. Droogmans, L., and Grosjean, H. (1987) EMBO J. 6, 477-483[Medline] [Order article via Infotrieve]
  35. Smith, C., Schmidt, P. G., Petsch, J., and Agris, P. F. (1985) Biochemistry 24, 1434-1440[Medline] [Order article via Infotrieve]
  36. Munch, H. J., and Thiebe, R. (1975) FEBS Lett. 51, 257-258[Medline] [Order article via Infotrieve]
  37. Pergolizzi, R. G., Engelhardt, D. L., and Grunberger, D. (1979) Nucleic Acids Res. 6, 2209-2216[Abstract/Free Full Text]
  38. Reader, J. S., Metzgar, D., Schimmel, P., and de Crécy-Lagard, V. (2004) J. Biol. Chem. 279, 6280-6285[Abstract/Free Full Text]
  39. Van Lanen, S. G., Reader, J. S., Swairjo, M. A., de Crécy-Lagard, V., Lee, B., and Iwata-Reuyl, D. (2005) Proc. Natl. Acad. Sci. U. S. A. 102, 4264-4269[Abstract/Free Full Text]
  40. Bishop, A. C., Xu, J., Johnson, R. C., Schimmel, P., and de Crécy-Lagard, V. (2002) J. Biol. Chem. 277, 25090-25095[Abstract/Free Full Text]
  41. Gerlt, J. A. (2003) Chem. Biol. 10, 1141-1142[Medline] [Order article via Infotrieve]
  42. Osterman, A., and Overbeek, R. (2003) Curr. Opin. Chem. Biol. 7, 238-251[CrossRef][Medline] [Order article via Infotrieve]
  43. Date, S. V., and Marcotte, E. M. (2005) Bioinformatics 21, 2558-2559[Abstract/Free Full Text]
  44. Datta, D., Wang, P., Carrico, I. S., Mayo, S. L., and Tirrell, D. A. (2002) J. Am. Chem. Soc. 124, 5652-5653[CrossRef][Medline] [Order article via Infotrieve]
  45. Schmidt, J., Wang, R., Stanfield, S., and Reid, B. R. (1971) Biochemistry 10, 3264-3268[Medline] [Order article via Infotrieve]
  46. Shepard, A., Shiba, K., and Schimmel, P. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 9964-9968[Abstract/Free Full Text]
  47. Keith, G., and Dirheimer, G. (1980) Biochem. Biophys. Res. Commun. 92, 109-115[Medline] [Order article via Infotrieve]
  48. Keith, G., Picaud, F., Weissenbach, J., Ebel, J. P., Petrissant, G., and Dirheimer, G. (1973) FEBS Lett. 31, 345-347[Medline] [Order article via Infotrieve]
  49. Guerrier-Takada, C., Dirheimer, G., Grosjean, H., and Keith, G. (1975) FEBS Lett. 60, 286-289[CrossRef][Medline] [Order article via Infotrieve]
  50. Keith, G., Ebel, J. P., and Dirheimer, G. (1974) FEBS Lett. 48, 50-52[Medline] [Order article via Infotrieve]
  51. Martin, R., Sibler, A. P., Schneller, J. M., Keith, G., Stahl, A. J., and Dirheimer, G. (1978) C. R. Acad. Sci. Hebd. Seances Acad. Sci. D 287, 845-848[Medline] [Order article via Infotrieve]
  52. Sprinzl, M., Steegborn, C., Hubel, F., and Steinberg, S. (1996) Nucleic Acids Res. 24, 68-72[Free Full Text]
  53. Altwegg, M., and Kubli, E. (1979) Nucleic Acids Res. 7, 93-105[Abstract/Free Full Text]
  54. Matte-Tailliez, O., Zivanovic, Y., and Forterre, P. (2000) Trends Genet. 16, 533-536[CrossRef][Medline] [Order article via Infotrieve]
  55. Armengaud, J., Urbonavicius, J., Fernandez, B., Chaussinand, G., Bujnicki, J. M., and Grosjean, H. (2004) J. Biol. Chem. 279, 37142-37152[Abstract/Free Full Text]
  56. Golankiewicz, B., Zielonacka-Lis, E., and Folkman, W. (1985) Nucleic Acids Res. 13, 2443-2449[Abstract/Free Full Text]
  57. Zhou, S., Sitaramaiah, D., Pomerantz, S. C., Crain, P. F., and McCloskey, J. A. (2004) Nucleosides Nucleotides Nucleic Acids 23, 41-50[Medline] [Order article via Infotrieve]
  58. Xue, H., Shen, W., and Wong, J. T. (1993) J. Chromatogr. 613, 247-255[Medline] [Order article via Infotrieve]
  59. Grunberger, D., Weinstein, I. B., and Mushinski, J. F. (1975) Nature 253, 66-67[CrossRef][Medline] [Order article via Infotrieve]
  60. Wimmer, E., Maxwell, I. H., and Tener, G. M. (1968) Biochemistry 7, 2623-2628[CrossRef][Medline] [Order article via Infotrieve]
  61. Taniguchi, H., and Hayashi, N. (1998) Nucleic Acids Res. 26, 1481-1486[Abstract/Free Full Text]
  62. Edmonds, C. G., Vestal, M. L., and McCloskey, J. A. (1985) Nucleic Acids Res. 13, 8197-8206[Abstract/Free Full Text]
  63. Pang, H., Smith, D. L., Crain, P. F., Yamaizumi, K., Nishimura, S., and McCloskey, J. A. (1982) Eur. J. Biochem. 127, 459-471[Medline] [Order article via Infotrieve]
  64. Vacher, J., Grosjean, H., Houssier, C., and Buckingham, R. H. (1984) J. Mol. Biol. 177, 329-342[CrossRef][Medline] [Order article via Infotrieve]
  65. Kuchino, Y., Borek, E., Grunberger, D., Mushinski, J. F., and Nishimura, S. (1982) Nucleic Acids Res. 10, 6421-6432[Abstract/Free Full Text]
  66. Kuchino, Y., Kasai, H., Yamaizumi, Z., Nishimura, S., and Borek, E. (1979) Biochim. Biophys. Acta 565, 215-218[Medline] [Order article via Infotrieve]
  67. Bjork, G. R., Jacobsson, K., Nilsson, K., Johansson, M. J., Bystrom, A. S., and Persson, O. P. (2001) EMBO J. 20, 231-239[CrossRef][Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
Y. Suzuki, A. Noma, T. Suzuki, R. Ishitani, and O. Nureki
Structural basis of tRNA modification with CO2 fixation and methylation by wybutosine synthesizing enzyme TYW4
Nucleic Acids Res., May 1, 2009; 37(9): 2910 - 2925.
[Abstract] [Full Text] [PDF]

Home page
 Microbiol. Mol. Biol. Rev.Home page
J. F. Atkins and G. R. Bjork
A Gripping Tale of Ribosomal Frameshifting: Extragenic Suppressors of Frameshift Mutations Spotlight P-Site Realignment
Microbiol. Mol. Biol. Rev., March 1, 2009; 73(1): 178 - 210.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W. F. Waas, Z. Druzina, M. Hanan, and P. Schimmel
Role of a tRNA Base Modification and Its Precursors in Frameshifting in Eukaryotes
J. Biol. Chem., September 7, 2007; 282(36): 26026 - 26034.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/45/37616    most recent
M506939200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waas, W. F.
Right arrow Articles by Schimmel, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waas, W. F.
Right arrow Articles by Schimmel, P.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement